Abcam Expresses Surprise At Dr. Milner's Actions, Believes His Opposition May Be An Attempt To Create Confusion Among Shareholders Before The Vote

Benzinga · 09/15/2023 06:07

Abcam plc (NASDAQ:ABCM) ("Abcam" or the "Company"), notes today's announcement by Dr. Jonathan Milner. The Company considers it surprising that Dr. Milner has taken active steps to oppose the deal without reviewing the full details in the Scheme Circular to be published in connection with the proposed acquisition of all of the outstanding shares of Abcam by Danaher Corporation ("Danaher") for $24.00 per share in cash (the "Transaction"), which appears to be an attempt to create confusion for shareholders ahead of voting on the Transaction.